Cargando…
Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction
OBJECTIVE: To evaluate the effect and safety of low-dose of apatinib and S-1 combined with Jianpi Bushen Jiedu Decoction (JBJD) in patients with metastatic colorectal cancer (mCRC) who have failed second or above lines treatment, in order to provide more treatment option for mCRC patients by integra...
Autores principales: | Chen, Yue, Xu, Yu-ying, Jiang, Hai-jun, Wang, Lei, Zhai, Jia-wei, Zhang, Tong, Yang, Yu-fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068502/ https://www.ncbi.nlm.nih.gov/pubmed/35508862 http://dx.doi.org/10.1007/s11655-022-3676-7 |
Ejemplares similares
-
Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer
por: Yang, Meng-Die, et al.
Publicado: (2021) -
Network Pharmacology-Based Study on the Mechanism of Bushen-Jianpi Decoction in Liver Cancer Treatment
por: Wu, Rong, et al.
Publicado: (2019) -
Constructing the Logical Regression Model to Predict the Target of Jianpi Jiedu Decoction in the Treatment of Hepatocellular Carcinoma
por: Zhang, Rongjie, et al.
Publicado: (2020) -
Therapeutic and Neuroprotective Effects of Bushen Jianpi Decoction on a Rotenone-Induced Rat Model of Parkinson's Disease
por: Liang, Wei, et al.
Publicado: (2022) -
Jianpi Qingchang Bushen decoction improves inflammatory response and metabolic bone disorder in inflammatory bowel disease-induced bone loss
por: Zhang, Ya-Li, et al.
Publicado: (2022)